Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia.

REFERENCES 1 Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycininduced immune thrombocytopenia. N Engl J Med 2007; 356: 904–910. 2 Documed. Product information dobutamine injection. Arzbeunuttel Kompendium der Schweiz. [Swiss Compendium of Therapeutic Drugs.] www.documed.ch Date last updated: 2005. Date last accessed: December 1, 2009. 3 George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Int Med 1998; 129: 886–890. 4 Lee SH, Rubin LJ. Current treatment strategies for pulmonary arterial hypertension. J Intern Med 2005; 258: 199–215. 5 US Food and Drug Administration. Ventavis (iloprost) inhalation solution September 2008. MedWatch FDA Safety Information and Adverse Event Reporting Program. Date last updated: June 19, 2009. Date last accessed: December 1, 2009. 6 Uppsala Monitoring Centre World Health Organization collaborating Centre for International Drug Monitoring. VigiBase Services. www.umc-products.com Date last accessed: December 1, 2009. 7 Chin KM, Channick RN, de Lemos JA, et al. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension. Chest 2009; 135: 130–136.